Company news: Daiichi Sankyo and GCI Health
North Shore-LIJ Health System named GCI Health as its PR agency of record. The company operates 15 hospitals in New York City and Long Island.
FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.
The $300,000 grant will go towards an abuse-deterrent technology.
A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.